100% Quality Guarantee
PhD-Level Technical Support
Anti-IL-4RA (dupilu biosimilar) (HDBS0051)
Key Features

Dupilumab Biosimilar (IL-4RA) Antibody (HDBS0051)

SKU HDBS0051
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein IL-4RA
Reactivity Human
Host Species Chimeric Humanized
Isotype IgG4
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Dupilumab Biosimilar (IL-4RA) Antibody (HDBS0051)

The IL-4RA (Dupilumab Biosimilar) Antibody (HDBS0051) is a cutting-edge research tool designed for studying the interleukin-4 receptor alpha (IL-4RA), a key component in the IL-4 signaling pathway. This monoclonal antibody, developed through advanced technology, specifically targets IL-4RA and is highly sensitive in detecting this protein in human samples.IL-4RA is a crucial receptor involved in immune responses and inflammatory processes, making it a promising target for therapeutic interventions in conditions such as allergic diseases, asthma, and autoimmune disorders.

By blocking the interaction between IL-4 and its receptor, this antibody can provide insights into the mechanisms underlying these diseases and aid in the development of novel treatment options.With its high specificity and sensitivity, the Anti-IL-4RA (Dupilumab Biosimilar) Antibody (HDBS0051) is a valuable tool for researchers in immunology, pharmacology, and drug development. Its ability to target IL-4RA opens up new possibilities for studying immune regulation and developing targeted therapies for a range of inflammatory conditions.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose